Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barry

Showing results (621-630 of 674) with videos related to

Pageof 68
Sort By:
Scientific Reports|December 10, 2015
Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slicesEmma J Davies, Meng Dong, Matthias Gutekunst, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2009
CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesisShauna N Vasilatos, Gloria Broadwater, William T Barry, et al.
Breast Cancer Research and Treatment|June 8, 2011
Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathwaysCatherine Ibarra-Drendall, Michelle M Troch, William T Barry, et al.
Nature Communications|September 30, 2020
Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discoveryAnders Lundin, Michelle J Porritt, Himjyot Jaiswal, et al.
Nature Biomedical Engineering|April 8, 2024
Histopathological biomarkers for predicting the tumour accumulation of nanomedicinesJan-Niklas May, Jennifer I Moss, Florian Mueller, et al.
Gynecologic Oncology|May 17, 2024
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparibJoyce F Liu, Niya Xiong, Robert M Wenham, et al.
Journal for Immunotherapy of Cancer|April 7, 2022
Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancerAlexey Revenko, Larissa S Carnevalli, Charles Sinclair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2018
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast CancerDaniel G Stover, Heather A Parsons, Gavin Ha, et al.
Nature Metabolism|May 19, 2025
Cell-intrinsic metabolic phenotypes identified in patients with glioblastoma, using mass spectrometry imaging of <sup>13</sup>C-labelled glucose metabolismAnastasia Tsyben, Andreas Dannhorn, Gregory Hamm, et al.
NPJ Breast Cancer|July 11, 2017
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)Minetta C Liu, Brandelyn N Pitcher, Elaine R Mardis, et al.
Pageof 68

Showing results (621-630 of 674) with videos related to

Sort By:
Pageof 68
Scientific Reports|December 10, 2015
Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slicesEmma J Davies, Meng Dong, Matthias Gutekunst, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2009
CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesisShauna N Vasilatos, Gloria Broadwater, William T Barry, et al.
Breast Cancer Research and Treatment|June 8, 2011
Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathwaysCatherine Ibarra-Drendall, Michelle M Troch, William T Barry, et al.
Nature Communications|September 30, 2020
Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discoveryAnders Lundin, Michelle J Porritt, Himjyot Jaiswal, et al.
Nature Biomedical Engineering|April 8, 2024
Histopathological biomarkers for predicting the tumour accumulation of nanomedicinesJan-Niklas May, Jennifer I Moss, Florian Mueller, et al.
Gynecologic Oncology|May 17, 2024
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparibJoyce F Liu, Niya Xiong, Robert M Wenham, et al.
Journal for Immunotherapy of Cancer|April 7, 2022
Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancerAlexey Revenko, Larissa S Carnevalli, Charles Sinclair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2018
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast CancerDaniel G Stover, Heather A Parsons, Gavin Ha, et al.
Nature Metabolism|May 19, 2025
Cell-intrinsic metabolic phenotypes identified in patients with glioblastoma, using mass spectrometry imaging of <sup>13</sup>C-labelled glucose metabolismAnastasia Tsyben, Andreas Dannhorn, Gregory Hamm, et al.
NPJ Breast Cancer|July 11, 2017
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)Minetta C Liu, Brandelyn N Pitcher, Elaine R Mardis, et al.
Pageof 68